Overview / Abstract: |
Target Audience This educational activity is directed toward neurologists and other health care providers who care for patients with MS. Program Overview This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of multiple sclerosis (MS) with a forward-looking perspective on how new and novel agents might impact clinical practice. The integration of biomarkers into diagnosis, efficacy of various disease-modifying therapies with a focus on the sphingosine-1-phosphate receptor modulator (S1PRM) class, and patient-focused risk assessment are presented in a multimedia format, including a series of video interviews with expert thought leaders integrated into text-based elements. Learning Objectives Upon completion of this activity, participants should be better able to: Assess the role of potential biomarkers and other key indicators of multiple sclerosis (MS) related to early diagnosis of MS |
Expiration |
May 24, 2023 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Bristol Myers Squibb. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., MS Free CE CME |